| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 4 buys and 12 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $267.27M | - | |
| Dir | 390.7K | $88.26M | - | |
| CEO | 152.2K | $34.38M | - | |
| VP | 72.6K | $16.41M | - | |
| CFO | 59.6K | $13.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2019 | Young Matthew P. | EVP &CFO | Sell | 1,152 | $135.41 | $155,992.32 | -3.1% | |
| Mar 1, 2019 | Treacy Paul | SVP, Technical Operations | Sell | 874 | $139.50 | $121,923.00 | -2.0% | |
| Feb 27, 2019 | Hooper Suzanne Sawochka | EVP &General Counsel | Sale+OE | 6,666 | $140.00 | $933,240.00 | -14.4% | |
| Feb 27, 2019 | Young Matthew P. | EVP &CFO | Sell | 1,916 | $131.46 | $251,872.20 | -3.2% | |
| Dec 14, 2018 | Hooper Suzanne Sawochka | EVP &General Counsel | Sale+OE | 3,334 | $140.21 | $467,460.14 | -3.9% | |
| Dec 3, 2018 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $151.78 | $151,780.00 | -0.4% | |
| Nov 23, 2018 | Young Matthew P. | EVP &CFO | Sell | 700 | $150.00 | $105,000.00 | -2.1% | |
| Nov 15, 2018 | Mulligan Seamus | Director | Buy | 50,000 | $144.56 | $7,228,001.03 | +1.2% | |
| Nov 13, 2018 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $149.27 | $29,854.00 | -0.8% | |
| Nov 1, 2018 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,300 | $159.45 | $207,289.94 | -0.5% |